PROLEUKIN
Live / Registered — Registered and renewed (as of 16 Jun 2025)
What this means for you
Registered since 23 Jun 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Jun 2025).
Record
- Serial number
- 86330987
- Registration number
- 4761828
- Mark type
- Design + words
- Filed
- 08 Jul 2014
- Published for opposition
- 13 Jan 2015
- Registered
- 23 Jun 2015
- Next maintenance due
- 23 Jun 2025
- Attorney of record
- Carla B. Oakley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of oncological diseases and disorders
Owner
- IOVANCE BIOTHERAPEUTICS MANUFACTURING LLC, PHILADELPHIA, PA, US
- CLINIGEN HOLDINGS LIMITED, STAFFORDSHIRE, GB
- Novartis Vaccines & Diagnostics, Inc., Cambridge, MA, US
- Novartis Vaccines & Diagnostics, Inc., Cambridge, MA, US
- Novartis Vaccines & Diagnostics, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 16 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Jun 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 Jun 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Jan 2025 — TEAS SECTION 8 & 9 RECEIVED
- 23 Jun 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 07 Feb 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Oct 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 14 Oct 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 14 Oct 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Aug 2020 — TEAS SECTION 8 & 15 RECEIVED
- 23 Jun 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Dec 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 23 Jun 2015 — REGISTERED-PRINCIPAL REGISTER
- 22 May 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED